美国的低剂量计算机断层扫描肺癌筛查——2010 年至 2015 年。
Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.
机构信息
Surveillance & Health Services Research, American Cancer Society, Atlanta, Georgia.
出版信息
JAMA Oncol. 2017 Sep 1;3(9):1278-1281. doi: 10.1001/jamaoncol.2016.6416.
Abstract
This study examines whether low-dose computed tomography screening for lung cancer increased following the United States Preventive Services Task Force recommendations.
摘要
本研究探讨了美国预防服务工作组的建议发布后，低剂量计算机断层扫描筛查肺癌的情况是否增加。
相似文献
1
Lung Cancer Screening With Low-Dose Computed Tomography in the United States-2010 to 2015.美国的低剂量计算机断层扫描肺癌筛查——2010 年至 2015 年。
JAMA Oncol. 2017 Sep 1;3(9):1278-1281. doi: 10.1001/jamaoncol.2016.6416.
2
Lung cancer screening.肺癌筛查。
Am J Respir Crit Care Med. 2015 Jan 1;191(1):19-33. doi: 10.1164/rccm.201410-1777CI.
3
Medicare Approves Coverage for Lung Cancer Screening: The Case for Symptomatic Screening.医疗保险批准肺癌筛查覆盖范围：症状性筛查的案例。
JAMA Oncol. 2015 Nov;1(8):1027-8. doi: 10.1001/jamaoncol.2015.2165.
4
Lung cancer screening trials: the United States and beyond.肺癌筛查试验：美国及其他国家
J Thorac Cardiovasc Surg. 2012 Sep;144(3):S3-6. doi: 10.1016/j.jtcvs.2012.05.027. Epub 2012 Jun 5.
5
ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4).美国放射学会（ACR）-美国放射学会胸科放射学会（STR）肺癌筛查胸部计算机断层扫描（CT）检查与报告的实践参数：2014年（第4号决议）
J Thorac Imaging. 2014 Sep;29(5):310-6. doi: 10.1097/RTI.0000000000000097.
6
7
Low-Dose Computed Tomography for Lung Cancer Screening: The Protocol and The Dose.低剂量计算机断层扫描用于肺癌筛查：方案与剂量
Semin Roentgenol. 2017 Jul;52(3):132-136. doi: 10.1053/j.ro.2017.06.002. Epub 2017 Jun 3.
8
Should patients newly diagnosed with bladder cancer be screened for lung cancer?新诊断出膀胱癌的患者应该接受肺癌筛查吗？
Int J Urol. 2016 Apr;23(4):346-7. doi: 10.1111/iju.13052. Epub 2016 Jan 14.
9
Task force recommends targeted lung cancer screening.特别工作组建议进行针对性肺癌筛查。
JAMA. 2013 Sep 4;310(9):892-3. doi: 10.1001/jama.2013.276646.
10
Lung Cancer Screening: Computed Tomography Radiation and Protocols.肺癌筛查：计算机断层扫描辐射与方案
J Thorac Imaging. 2015 Sep;30(5):283-9. doi: 10.1097/RTI.0000000000000150.
引用本文的文献
1
Patient-clinician discussions on lung cancer screening in the United States before and after 2021 guidelines.2021年指南前后美国患者与临床医生关于肺癌筛查的讨论。
Transl Behav Med. 2025 Jan 16;15(1). doi: 10.1093/tbm/ibaf039.
2
Provider readiness and implementation barriers for lung cancer screening in a safety-net system.安全网系统中肺癌筛查的医疗服务提供者准备情况及实施障碍
Prev Med Rep. 2025 Jul 3;56:103164. doi: 10.1016/j.pmedr.2025.103164. eCollection 2025 Aug.
3
A Trend Analysis of Metastatic Lung Cancer Disparities in the United States in the Era of Lung Cancer Screening.肺癌筛查时代美国转移性肺癌差异的趋势分析
Cureus. 2025 Jun 1;17(6):e85184. doi: 10.7759/cureus.85184. eCollection 2025 Jun.
4
Multi-level factors associated with low dose computed tomography lung cancer screening in the United States.美国低剂量计算机断层扫描肺癌筛查的多层面相关因素。
J Natl Med Assoc. 2025 Aug;117(4):225-234. doi: 10.1016/j.jnma.2025.05.002. Epub 2025 May 29.
5
Lung Cancer Screening Rates in the United States: Contribution of the 2020 NHIS Estimates to National and State-Level Trends.美国肺癌筛查率：2020年美国国家健康访谈调查（NHIS）估计值对国家和州层面趋势的贡献。
Am J Prev Med. 2025 Jul;69(1):107626. doi: 10.1016/j.amepre.2025.03.006. Epub 2025 Mar 27.
6
The Use of CT Densitometry for the Assessment of Emphysema in Clinical Trials: A Position Paper from the Fleischner Society.CT密度测定法在临床试验中用于评估肺气肿：来自弗莱施纳学会的立场文件。
Am J Respir Crit Care Med. 2025 Mar 24;211(5):709-28. doi: 10.1164/rccm.202410-2012SO.
7
5-Hydroxymethylcytosine modifications in circulating cell-free DNA: frontiers of cancer detection, monitoring, and prognostic evaluation.循环游离DNA中的5-羟甲基胞嘧啶修饰：癌症检测、监测及预后评估的前沿领域
Biomark Res. 2025 Mar 7;13(1):39. doi: 10.1186/s40364-025-00751-9.
8
Trends and regional variations in chronic ischemic heart disease and lung cancer-related mortality among American adults: Insights from retrospective CDC wonder analysis.美国成年人慢性缺血性心脏病和肺癌相关死亡率的趋势及地区差异：来自疾病控制与预防中心（CDC）Wonder回顾性分析的见解
Int J Cardiol Cardiovasc Risk Prev. 2025 Feb 14;24:200377. doi: 10.1016/j.ijcrp.2025.200377. eCollection 2025 Mar.
9
The feasibility and cost-effectiveness of implementing mobile low-dose computed tomography with an AI-based diagnostic system in underserved populations.在服务不足人群中实施配备基于人工智能诊断系统的移动低剂量计算机断层扫描的可行性和成本效益。
BMC Cancer. 2025 Feb 25;25(1):345. doi: 10.1186/s12885-025-13710-2.
10
Development and biological evaluation of a novel CEACAM6-targeted PET tracer for distinguishing malignant nodules in early-stage lung adenocarcinoma.一种用于鉴别早期肺腺癌恶性结节的新型CEACAM6靶向PET示踪剂的研发与生物学评价
Eur J Nucl Med Mol Imaging. 2025 Jan 31. doi: 10.1007/s00259-025-07107-3.
本文引用的文献
1
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
2
Knowledge of, attitudes toward, and use of low-dose computed tomography for lung cancer screening among family physicians.家庭医生对低剂量计算机断层扫描用于肺癌筛查的了解、态度及使用情况。
Cancer. 2016 Aug 1;122(15):2324-31. doi: 10.1002/cncr.29944. Epub 2016 Jun 13.
3
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.肺癌筛查：美国预防服务工作组推荐声明。
Ann Intern Med. 2014 Mar 4;160(5):330-8. doi: 10.7326/M13-2771.
4
American Cancer Society lung cancer screening guidelines.美国癌症协会肺癌筛查指南。
CA Cancer J Clin. 2013 Mar-Apr;63(2):107-17. doi: 10.3322/caac.21172. Epub 2013 Jan 11.
5
Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.美国肺癌筛查试验的使用情况：来自 2010 年全国健康访谈调查的结果。
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1049-59. doi: 10.1158/1055-9965.EPI-12-0343. Epub 2012 May 9.
Zotero 插件